Delivery Order 75D30124D20037-75D30124F00004
Award Date
9/27/24
Potential Completion Date
9/26/25
Potential Value
$493K
Federal Agency
CDC Pittsburgh
Awardee
Quest Diagnostics Incorporated
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Secaucus, NJ 07094, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,631,042.24 Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Quest Diagnostics Incorporated by the Centers for Disease Control and Prevention (CDC) to provide test surge and data sharing services. The contract has an ultimate completion date of September 26, 2029. This IDIQ contract is part of the broader "Test Surge and Data Sharing Multiple Award IDIQ" and does not have a set-aside designation. Under this contract, Quest Diagnostics will provide a...
This is a federal contract award to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, by the Centers for Disease Control and Prevention (CDC) for a Test Surge and Data Sharing Multiple Award Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $3,636,702.00 and an ultimate completion date of September 26, 2029. The contract is for delivery orders and is a Firm Fixed Price type. The contract does not have a set-aside designation. Quest...
This is a $4,470,182.84 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a provider of diagnostic information services. The contract is for "QUEST DIAGNOSTICS DATA" and has a period of performance through March 3, 2025. Quest Diagnostics has previously provided COVID-19 and other infectious disease testing services, as well as reference laboratory testing support, to various federal agencies...
The Centers for Disease Control and Prevention (CDC) awarded a $14 million firm fixed price delivery order contract to Quest Diagnostics Incorporated for surge serology testing services. Under the contract, Quest Diagnostics will provide COVID-19 antibody testing from its laboratory located in Secaucus, New Jersey to support the CDC's pandemic response efforts. The period of performance is from July 30, 2020 through November 19, 2020. No set aside designation or subcontractors were identified....
This is a $24,691,200 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated for serology testing services. The contract has a period of performance through March 5, 2022 and was awarded on November 13, 2020 without any set-aside designation. Quest Diagnostics, a for-profit diagnostic information services provider, has previously supported federal agencies such as the Department of Justice's Bureau of Prisons, the...
This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, for data submission services. The contract is a definitive, firm fixed-price contract with a potential value of $722,500.00. The purpose is to obtain laboratory test order and test result data, including longitudinal patient identifiers but without personally identifiable information, to...
The Centers for Disease Control and Prevention awarded a firm-fixed price contract valued at $1,676,070.04 to Quest Diagnostics Clinical Laboratories, Inc. to meet requirements established in a January 2020 solicitation. The solicitation sought longitudinal laboratory test order and result data for hosting in CDC's Data Hub to support analyses of public health trends related to reportable diseases and exposures over time. Only Quest could fulfill this requirement due to its market share and...
The Centers for Disease Control and Prevention (CDC) awarded a $4,429,789.59 firm-fixed-price contract to Quest Diagnostics Incorporated, a large diagnostic information services provider, to maintain approximately 20,000 COVID-19 testing sites nationwide through the Increasing Community Access to Testing (ICATT) program. This contract, which does not have a set-aside designation, is part of the CDC's efforts to increase equitable access to COVID-19 testing by partnering with private sector...
This is a $74,393,160.50 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a large for-profit diagnostic information services provider. The contract is for COVID-19 genomic sequencing services and has a completion date of April 22, 2025. The contract is a firm-fixed-price type and does not utilize any set-aside designations. Quest Diagnostics has a strong track record of providing reference laboratory testing and diagnostic...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Clinical Laboratories, Inc., a subsidiary of Quest Diagnostics Incorporated, for $92,922.00 in laboratory services. The contract is for the provision of comprehensive diagnostic testing solutions, including drug and alcohol testing, COVID-19 testing, and specialized diagnostic analyses, to support various federal healthcare, law enforcement, and workplace safety...